Table 3 Aggregated costs of the most prevalent and expensive dyads and triads (in 2022 Euro)
From: Multimorbidity healthcare expenditure in Belgium: a 4-year analysis (COMORB study)
Type | Morbidity combination | Prevalence rate | Average direct cost per person per year | Total cost on the population level | As % of total health expenditure |
|---|---|---|---|---|---|
Most prevalent dyad | Arthropathies + dorsopathies | 14.1% (95% CI 13.1–15.1) | €3044 (95% CI 2296–3792) | €4,070,766,024 | 11% |
Most expensive dyad | Cancer + chronic fatigue | 0.8% (95% CI 0.48–1.04) | €8345 (95% CI 4998–11,691) | €633,182,216 | 2% |
Most prevalent triad | Arthropathies + dorsopathies + hypertension | 5.2% (95% CI 4.6–5.8) | €3894 (95% CI 2725–5063) | €1,920,488,324 | 5% |
Most expensive triad | Cancer + chronic fatigue + diabetes | 0.1% (95% CI 0.02–0.17) | €20,244 (95% CI 11,397–29,090) | €192,003,307 | 1% |